TKPHF - Takeda Pharmaceutical GAAP EPS of ¥425.00 revenue of ¥3.42T May, 11 2022 02:26 AM Takeda Pharmaceutical Co Ltd Takeda Pharmaceutical press release (NYSE:TAK): FY GAAP EPS of ¥425.00. Revenue of ¥3.42T (+7.4% Y/Y). For further details see: Takeda Pharmaceutical GAAP EPS of ¥425.00, revenue of ¥3.42T